Alvotech (NASDAQ:ALVO) is one of the best oversold NASDAQ stocks to buy now. On July 9, Alvotech (NASDAQ:ALVO) announced that ...

Alvotech (ALVO) has been on a downward spiral lately with significant selling pressure. After declining 6.6% over the past ...

Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...

Sarepta Therapeutics (SRPT) said a third patient has died from acute liver failure after receiving one of its gene therapies, ...

The "Ophthalmics Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of 344 ophthalmics ...

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Dr. Reddy's reports Q1 earnings on July 23. before market open. Over the last 1 year, RDY has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.